Armata Pharmaceuticals, Inc. (ARMP) Earnings History
Annual and quarterly earnings data from 1993 to 2024
Loading earnings history...
ARMP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ARMP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -565.4% | -820.2% | -365.6% |
| 2023 | 78.5% | -902.8% | -1524.5% |
| 2022 | -535.7% | -670.8% | -670.2% |
| 2021 | -347.4% | -532.5% | -517.5% |
| 2020 | -1655.0% | -2623.0% | -2695.1% |
Download Data
Export ARMP earnings history in CSV or JSON format
Free sign-in required to download data
Armata Pharmaceuticals, Inc. (ARMP) Earnings Overview
As of May 8, 2026, Armata Pharmaceuticals, Inc. (ARMP) reported trailing twelve-month net income of -$47M, reflecting +72.6% year-over-year growth. The company earned $-1.29 per diluted share over the past four quarters, with a net profit margin of -365.6%.
Looking at the long-term picture, ARMP's historical earnings data spans multiple years. The company achieved its highest annual net income of $23M in fiscal 2014.
Armata Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PHGE (-$36M net income), LSTA (-$17M net income, -9756.5% margin), SIGA (-$4.04T net income, 24.6% margin), ARMP has comparable earnings metrics. Compare ARMP vs PHGE →
ARMP Earnings vs Peers
Earnings metrics vs comparable public companies
ARMP Historical Earnings Data (1993–2024)
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$19M | +72.6% | -$42M | $-0.52 | -365.6% | -820.2% |
| 2023 | -$69M | -87.0% | -$41M | $-1.91 | -1524.5% | -902.8% |
| 2022 | -$37M | -59.4% | -$37M | $-1.08 | -670.2% | -670.8% |
| 2021 | -$23M | -4.4% | -$24M | $-0.96 | -517.5% | -532.5% |
| 2020 | -$22M | -13.9% | -$22M | $-1.35 | -2695.1% | -2623.0% |
| 2019 | -$19M | -60.9% | -$19M | $-2.43 | - | - |
| 2018 | -$12M | +5.7% | -$13M | $-8.90 | - | - |
| 2017 | -$13M | +31.9% | -$16M | $-27.34 | -11163.5% | -14048.7% |
| 2016 | -$19M | -3550.8% | -$23M | $-345.80 | -7245.4% | -8991.5% |
| 2015 | $-516,000 | -102.2% | -$10M | $-278.60 | -108.6% | -2153.1% |
See ARMP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARMP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ARMP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonARMP — Frequently Asked Questions
Quick answers to the most common questions about buying ARMP stock.
Is ARMP growing earnings?
ARMP EPS is $-1.29, with earnings growth accelerating to +72.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-47M.
What are ARMP's profit margins?
Armata Pharmaceuticals, Inc. net margin is -365.6%, with operating margin at -820.2%. Below-average margins reflect competitive or cost pressures.
How consistent are ARMP's earnings?
ARMP earnings data spans 1993-2024. The accelerating earnings trend is +72.6% YoY. Historical data enables comparison across business cycles.